Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00829_DB06414_nanopub.RAOhKkRm3ozc9qrN_KRp9vNHuXLPx_D0yMYCbID3gEWP8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00829_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00829_DB06414 label "DDI between Diazepam and Etravirine - Diazepam (a CYP21C9 and CYP3A4 substrate), when administered concomitantly with etravirine, may experience an increase (via CYP21C9 inhibition) or a decrease(via CYP3A4 induction) in serum concentration. Overall clinical significance is unknown. It is recommended to monitor diazepam therapy. [drugbank_resource:DB00829_DB06414]" assertion.
- drugbank_resource:DB00829_DB06414 identifier "drugbank_resource:DB00829_DB06414" assertion.
- drugbank_resource:DB00829_DB06414 title "DDI between Diazepam and Etravirine - Diazepam (a CYP21C9 and CYP3A4 substrate), when administered concomitantly with etravirine, may experience an increase (via CYP21C9 inhibition) or a decrease(via CYP3A4 induction) in serum concentration. Overall clinical significance is unknown. It is recommended to monitor diazepam therapy." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00829_DB06414 assertion.
- drugbank:DB00829 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00829_DB06414 assertion.